The Lyophilisation for Pharmaceuticals Products and Services Market will reach $3.45bn in 2015

 
 
vg
vg
LONDON - Jan. 26, 2015 - PRLog -- London, UK, 16th of January 2015: A new report by visiongain calculates that the lyophilisation for pharmaceuticals products and services market will reach $3.45bn in 2015 with revenue showing steady growth to 2025. These forecasts and others appear in Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Prospects for Leading Companies (https://www.visiongain.com/Report/1378/Lyophilisation-for-Pharmaceuticals-Products-and-Services-2015-2025-Future-Prospects-for-Leading-Companies), published in January 2015.Visiongain (https://www.visiongain.com/) is a business intelligence company based in London, UK.

The growth in the lyophilisation for pharmaceuticals market (https://www.visiongain.com/Sector/8/Pharma) will mainly be driven by the growth in the biopharmaceuticals market, with many of these drugs requiring freeze drying for stabilisation, ease of reconstitution and extended shelf life. There will also be double-digit growth in the emerging markets which still remain largely underpenetrated. Accelerated growth is expected in the emerging markets such as Brazil, Russia, India and China, Mexico, South Korea and Turkey.

Amy To, pharmaceutical and medical devices analyst at visiongain explains: “There has been a fast growing demand for lyophilisation services over the last few years, with many CMOs expanding their freeze drying facilities as part of their growth strategy. There are new technologies that have emerged to improve the lyophilisation process such as process Analytical Technologies (PAT) and controlled nucleation techniques such as ICE Fog.  These advances should optimise the freeze dry cycle to maximise process efficiency and thus reduce high running costs and product formulation challenges.

On the other hand, there are competing technologies that will somewhat restrain growth in the lyophilisation products and services market. The most significant substitute technology is spray drying because it is much more of an economical process as compared to lyophilisation. However the process of spray drying is not suitable for many biopharmaceutical products and therefore lyophilisation will remain the preferred method over the forecast period.”

Visiongain’s brand new 222 page report provides revenue forecasts to 2025 for the world lyophilisation for pharmaceuticals market and leading regional and national markets. It forecasts sales in the US, Japan, Germany, France, Italy, Spain, UK, China, India, Russia, Brazil, Turkey, Mexico and South Korea. The report also forecasts sales for the submarket cGMP lyophilisers, laboratory lyophilisers, lyophilisation services and forecasts for its most prominent pharmaceutical applications (monoclonal antibodies, insulin, interferons, other recombinant hormones, plasma and recombinant coagulation factors, other protein therapeutics, biosimilars and vaccines). It also includes three exclusive interviews with industry experts within the lyophilisation industry.

Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies adds to visiongain’s range of analytical reports on industries and markets in healthcare.

For sample pages and further information concerning the visiongain Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies report please visit: https://www.visiongain.com/Report/1378/Lyophilisation-for-Pharmaceuticals-Products-and-Services-2015-2025-Future-Prospects-for-Leading-Companies

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com

Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail tosara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first portofcall for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Contact
Sara Peerun
***@visiongainglobal.com
End
Visiongain PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share